Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 11

Results For "LAC"

1980 News Found

AstraZeneca reports major Phase III breakthrough in IgA kidney disease trial
Clinical Trials | June 09, 2026

AstraZeneca reports major Phase III breakthrough in IgA kidney disease trial

At 34 weeks, Ultomiris achieved a 43.4% placebo-adjusted reduction in 24-hour urine protein creatinine ratio (UPCR) versus placebo, meeting the study’s key interim endpoint


Mariska Hargitay launches Bristol Myers Squibb's Myeloma Awareness Campaign
News | June 09, 2026

Mariska Hargitay launches Bristol Myers Squibb's Myeloma Awareness Campaign

The campaign places renewed focus on a disease that remains incurable despite major scientific advances


Wegovy pill smashes past 3mn prescriptions in under six months in US
News | June 09, 2026

Wegovy pill smashes past 3mn prescriptions in under six months in US

The company said Wegovy hit its first one million prescriptions within 12 weeks of availability


Pfizer reports strong mid-stage results for monthly GLP-1 drug berobenatide
News | June 09, 2026

Pfizer reports strong mid-stage results for monthly GLP-1 drug berobenatide

The company said data from multiple VESPER studies show the peptide delivered meaningful weight loss, favorable tolerability, and the possibility of a first-in-class monthly injection format


Bayer brings Alka-Seltzer to India touting first antacid with probiotic support
News | June 09, 2026

Bayer brings Alka-Seltzer to India touting first antacid with probiotic support

The launch comes against the backdrop of a significant public health burden


FDA expands Pfizer’s HYMPAVZI approval
Drug Approval | June 09, 2026

FDA expands Pfizer’s HYMPAVZI approval

Broadening access for children & patients with inhibitor-complicated hemophilia


Novo Nordisk's Zenagamtide shows strong HbA1c and weight loss benefits in phase II trial
R&D | June 08, 2026

Novo Nordisk's Zenagamtide shows strong HbA1c and weight loss benefits in phase II trial

Investigational once-weekly GLP-1 and amylin receptor agonist achieves up to 14.6% weight loss and significant blood sugar reductions


Finerenone expands promise beyond diabetic kidney disease
Clinical Trials | June 05, 2026

Finerenone expands promise beyond diabetic kidney disease

The drug currently approved for chronic kidney disease (CKD) associated with type 2 diabetes, may benefit a much broader group of patients than previously recognized


SS Innovations sets world record with longest-distance robotic cardiac telesurgery
Medical Device | June 05, 2026

SS Innovations sets world record with longest-distance robotic cardiac telesurgery

The robotic cardiac procedure between Guyana and India, established a new benchmark in global telesurgery across nearly 20,000 kilometres